Premium
Rituximab, lenalidomide and pembrolizumab in refractory primary cutaneous diffuse large B‐cell lymphoma, leg type
Author(s) -
Di Raimondo Cosimo,
Abdulla Farah R.,
Zain Jasmine,
Querfeld Christiane,
Rosen Steven T.
Publication year - 2019
Publication title -
british journal of haematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.907
H-Index - 186
eISSN - 1365-2141
pISSN - 0007-1048
DOI - 10.1111/bjh.16211
Subject(s) - lenalidomide , rituximab , pembrolizumab , medicine , refractory (planetary science) , lymphoma , dermatology , oncology , multiple myeloma , immunotherapy , cancer , materials science , composite material
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom